EORTC partners with IBBL to support precision medicine clinical research

This partnership will ensure that the significant strengths of both organizations will combine to allow expansion of their respective portfolios.

“We strive to form a network of professional not-for-profit institutions that is much more than the sum of its parts. Our vision is to always produce highest-quality research, aiming for robustness, reproducibility, and reduction of bias,” said Vassilis Golfinopoulos, Medical Director at EORTC. “By working with IBBL and building on the SPECTA infrastructure, we offer to European researchers a research platform with a level of quality and cost-effectiveness only available to a few select institutions so far. This system will open more opportunities for clinicians to develop innovative trials and valuable translational research.”

EORTC’s SPECTA initiative is a pan-European biobank and molecular profiling platform for patients in colorectal, brain, lung, melanoma, and rare cancers, which aims to optimize drug access, help advance the development of targeted treatments and accelerate new healthcare delivery. Built as a collaborativenetwork, SPECTA provides access to large sets of patient-level clinical and biological data for international, multidisciplinary clinical research.

“We are proud to become EORTC’s partner of choice for the management and storage of biosamples in the context of their clinical research,” said Marc Vandelaer, CEO of IBBL. “This partnership supports our mission of providing accredited bioservices and a biobanking infrastructure for applied medical research.”

About EORTC

The European Organisation for the Research and Treatment of Cancer (EORTC) brings together European cancer clinical research experts from all disciplines for trans-national collaboration. Both multinational and multidisciplinary, the EORTC network comprises more than 4,600 collaborators from all disciplines involved in cancer treatment and research in more than 640 hospitals in over 37 countries. A unique pan-European non-profit clinical research infrastructure, EORTC offers an integrated approach to drug development, drug evaluation programs and medical practices through translational and clinical research. www.eortc.org